Search Results - "Burris, H A 3rd"

Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.

Authors: Hainsworth, John D. Burris III, Howard A. Calvert, Sharon W. et al.

Source: Cancer Investigation. Apr2001, Vol. 19 Issue 4, p335-339. 5p. 2 Charts.

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies.

Authors: Tan, A R Dowlati, A Stein, M N et al.

Source: British Journal of Cancer. 2014 May 27, Vol. 110 Issue 11, p2647-2654. 8p.

Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.

Authors: Hoh, C K Burris 3rd, H A Bendell, J C et al.

Source: British Journal of Cancer. 2/18/2014, Vol. 110 Issue 4, p875-881. 7p.

Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer.

Authors: Kolesar JM Kuhn JG Burris HA 3rd et al.

Source: JNCI: Journal of the National Cancer Institute. 7/5/95, Vol. 87 Issue 13, p1022-1024. 3p.

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Authors: Burris HA 3rd Moore MJ Andersen J et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5482-5492.

Publication Type: Clinical Trial; Research Support, Non-U.S. Gov't; Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE

Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.

Authors: Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN 37203, USA. howard.burris@scresearch.net

Source: Oncogene [Oncogene] 2009 Aug; Vol. 28 Suppl 1, pp. S4-13.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.

Authors: Ajani JA Safran H Bokemeyer C et al.

Source: Investigational new drugs [Invest New Drugs] 2006 Sep; Vol. 24 (5), pp. 441-6.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.

Authors: Hong DS Bauer TM Lee JJ et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Feb 01; Vol. 30 (2), pp. 325-331.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors.

Authors: Tolcher AW Bendell JC Papadopoulos KP et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Jan; Vol. 26 (1), pp. 58-64. Date of Electronic Publication: 2014 Oct 24.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

Authors: Piccart M Hortobagyi GN Campone M et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Dec; Vol. 25 (12), pp. 2357-2362. Date of Electronic Publication: 2014 Sep 17.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.

Authors: Rini B Redman B Garcia JA et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Sep; Vol. 25 (9), pp. 1794-1799. Date of Electronic Publication: 2014 Jun 08.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Authors: Rugo HS Pritchard KI Gnant M et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Apr; Vol. 25 (4), pp. 808-815. Date of Electronic Publication: 2014 Mar 10.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Authors: Hainsworth JD Burris HA 3rd Billings FT 3rd et al.

Source: Cancer [Cancer] 2001 Nov 01; Vol. 92 (9), pp. 2391-8.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.

Authors: Greco FA Burris HA 3rd Gray JR et al.

Source: Cancer [Cancer] 2001 Oct 15; Vol. 92 (8), pp. 2142-7.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.

Authors: Hainsworth JD Burris HA 3rd Meluch AA et al.

Source: Cancer [Cancer] 2001 Aug 01; Vol. 92 (3), pp. 642-9.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

Authors: Hainsworth JD Burris HA 3rd Yardley DA et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2001 Aug 01; Vol. 19 (15), pp. 3500-5.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Authors: Meluch AA Greco FA Burris HA 3rd et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2001 Jun 15; Vol. 19 (12), pp. 3018-24.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

Authors: Hainsworth JD Burris HA 3rd Greco FA

Source: Seminars in oncology [Semin Oncol] 2001 Jun; Vol. 28 (3 Suppl 9), pp. 21-5.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print Cited Medium: Print ISSN: 0093-7754 (Print) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE

Taxane-based chemotherapy for patients with carcinoma of unknown primary site.

Authors: Greco FA Gray J Burris HA 3rd et al.

Source: Cancer journal (Sudbury, Mass.) [Cancer J] 2001 May-Jun; Vol. 7 (3), pp. 203-12.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100931981 Publication Model: Print Cited Medium: Print ISSN: 1528-9117 (Print) Linking ISSN: 15289117 NLM ISO Abbreviation: Cancer J Subsets: MEDLINE

Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.

Authors: Hainsworth JD Burris HA 3rd Greco FA

Source: Seminars in oncology [Semin Oncol] 2001 Apr; Vol. 28 (2 Suppl 4), pp. 43-7.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print Cited Medium: Print ISSN: 0093-7754 (Print) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE